IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Cambrex Reports Rise in Profits and Sales

12:27 AM MDT | May 4, 2012 | Deepti Ramesh

Cambrex (East Rutherford, NJ) reported a more than doubling in net profits for the first quarter ended March 31, 2012, compared with the year-ago quarter, to $7 million. Net sales for the quarter increased 14%, to $70 million, primarily due to higher sales volumes of controlled substances and generic active pharmaceutical ingredients (APIs), Cambrex says.       The strong sales and profit growth in the first quarter are “driven by most of our product categories,” says Steven M. Klosk, president and CEO of Cambrex...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa